Loading...
Thumbnail Image
Publication

Prostate Cancer: Advances in Radiation Oncology, Molecular Biology, and Future Treatment Strategies

Wang, Tao
Lewis, Brian
Ruscetti, Marcus
Mittal, Kriti
Wang, Ming-Jin
Sokoloff, Mitchell H.
Ding, Linda
Bishop-Jodoin, Maryann
FitzGerald, Thomas J
Embargo Expiration Date
Abstract

Prostate cancer remains an important health problem worldwide affecting one in every six men including members of vulnerable communities. Although successful treatments have been delivered to men affected with the disease resulting in improved patient outcome, process improvements including therapy titration and augmentation are needed to optimize tumor control and limit normal tissue injury from therapy. In this chapter, we describe current management strategies for optimal patient care with radiation therapy and opportunities for improvement of care moving forward with applied science to apply therapy in a strategic manner, potentially improving care and outcome for patients treated for this disease.

Source

Wang T, Lewis B, Ruscetti M, Mittal K, Wang MJ, Sokoloff M, Ding L, Bishop-Jodoin M, FitzGerald TJ. Prostate Cancer: Advances in Radiation Oncology, Molecular Biology, and Future Treatment Strategies. In: Barber N, Ali A, editors. Urologic Cancers [Internet]. Brisbane (AU): Exon Publications; 2022 Sep 12. Chapter 13. PMID: 36343136.

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.36255/exon-publications-urologic-cancers-prostate-cancer-radiation-oncology
PubMed ID
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
Copyright: The Authors. The authors confirm that the materials included in this chapter do not violate copyright laws. Where relevant, appropriate permissions have been obtained from the original copyright holder(s), and all original sources have been appropriately acknowledged or referenced. Licence: This open access article is licenced under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) https://creativecommons.org/licenses/by-nc/4.0/Attribution-NonCommercial 4.0 International